Fulgent Genetics, Inc. (FLGT) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 34 days, typically, give or take 12 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Thu, Nov 5, 2026after close 36 8-K
Q2 FY2026Thu, Jul 30, 2026after close 30 8-K
Q1 FY2026Fri, May 1, 2026before open 31 8-K
Q4 FY2025Fri, Feb 27, 2026before open 58 8-K
Q3 FY2025Fri, Nov 7, 2025before open 38 8-K
Q2 FY2025Fri, Aug 1, 2025before open 32 8-K
Q1 FY2025Fri, May 2, 2025before open 32 8-K
Q4 FY2024Fri, Feb 28, 2025before open 59 8-K

What they guided beta

Q3 FY2026 "Improves outlook for annual Non-GAAP loss and cash guidance, as a result of disciplined spend across the business EL MONTE, CA, November 5, 2026 — Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its third quarter ended September 30, 2026." exhibit
Q3 FY2026 "Outlook : For the full year 2026, Fulgent expects:" exhibit
Q3 FY2026 "For the full year 2026, Fulgent now expects:" exhibit
Q3 FY2026 "Cash, cash equivalents, restricted cash, and investments in marketable securities of approximately $630.0 million, which includes $64.1 million of cash used for the stock repurchase program, year to date as of September 30, 2026* *Cash expenditures may be higher or lower than currently estimated due to a variety of factors and circumstances, including as a result of the Company’s ongoing stock repurchase program, or other expenditures outside the ordinary course of business, including M&A." exhibit
Q2 FY2026 "Revised annual revenue guidance to be in the range of $330.0-$340.0 million EL MONTE, CA, July 30, 2026 — Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its second quarter ended June 30, 2026." exhibit
Q2 FY2026 "Outlook : For the full year 2026, Fulgent now expects:" exhibit
Q2 FY2026 "Cash, cash equivalents, restricted cash, and investments in marketable securities of approximately $610.0 million, which includes $63.9 million cash used for the stock repurchase program, year to date as of June 30, 2026* *Cash expenditures may be higher or lower than currently estimated due to a variety of factors and circumstances, including as a result of the Company’s ongoing stock repurchase program, or other expenditures outside the ordinary course of business, including M&A." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/FLGT
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/FLGT

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

FLGT earnings date badge

HTML

<a href="https://veritasdata.dev/company/FLGT/"><img src="https://veritasdata.dev/embed/FLGT.svg" alt="FLGT earnings date" width="240" height="56"></a>

Markdown

[![FLGT earnings date](https://veritasdata.dev/embed/FLGT.svg)](https://veritasdata.dev/company/FLGT/)

Script

<script async src="https://veritasdata.dev/embed/FLGT.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/FLGT"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.